Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages

Regulatory Peptides

Volumn 148, Issue 1-3, 2008, Pages 26-32

  Chiurchiu V ^a   Izzi, V ^a   D'Aquilio, F ^a   Carotenuto, F ^a   Di Nardo, P ^a   Baldini, P M ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Arachidonic acid metabolism; Cytokines; Natriuretic peptides; RNS; ROS

Indexed keywords

ARACHIDONIC ACID; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; DICHLORODIHYDROFLUORESCEIN DIACETATE; INTERLEUKIN 10; INTERLEUKIN 12; LEUKOTRIENE B4; NITRITE; PROSTAGLANDIN E2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MACROPHAGE MIGRATION; MEDIATOR RELEASE; PRIORITY JOURNAL; SEPTIC SHOCK; STATISTICAL ANALYSIS; VASODILATATION; WOUND HEALING;

ARACHIDONIC ACID; CELL LINE; CELL MOVEMENT; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOTRIENE B4; MACROPHAGES; NATRIURETIC PEPTIDE, BRAIN; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44349116177     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.02.009     Document Type: Article

References (35)

1. Azzazy H.M., and Christenson R.H. B-type natriuretic peptide: physiological role and assay characteristics. Heart Fail Rev 8 (2003) 315-320
2. Dhingra H., Roongsritong C., and Kurtzman N.A. Brain natriuretic peptide: role in cardiovascular and volume homeostasis. Semin Nephrol 22 (2002) 423-437
3. Gerbes A.L., Dagnino L., Nguyen T., and Nemer M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab 78 (1994) 1307-1311
4. Rudiger A., Gasser S., Fischler M., Hornemann T., von Eckardstein A., and Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 38 (2006) 2140-2144
5. Charpentier J., Luyt C.E., Fulla Y., Vinsonneau C., Cariou A., Grabar S., Dhainaut J.F., Mira J.P., and Chiche J.D. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 (2004) 660-665
6. Papp A., Uusaro A., Parviainen I., Hartikainen J., and Ruokonen E. Myocardial function and haemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography and cytokine concentrations. A prospective clinical study. Acta Anaesthesiol Scand 47 (2003) 1257-1263
7. Tanaka T., Kanda T., Takahashi T., Saegusa S., Moriya J., and Kurabayashi M. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 32 (2004) 57-61
8. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 (2004) 505-513
9. Vollmar A.M., Schmidt K.N., and Schulz R. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide. Endocrinology 137 (1996) 1706-1713
10. Vollmar A.M., and Schulz R. Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest 95 (1995) 2442-2450
11. Billack B. Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am J Pharm Educ 70 (2006) 102
12. Shen H.M., Shi C.Y., Shen Y., and Ong C.N. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic Biol Med 21 (1996) 139-146
13. Zannetti A., Luly P., Musanti R., and Baldini P.M. Phosphatidylinositol- and phosphatidylcholine-dependent phospholipases C are involved in the mechanism of action of atrial natriuretic factor in cultured rat aortic smooth muscle cells. J Cell Physiol 170 (1997) 272-278
14. Pixley F.J., Lee P.S., Condeelis J.S., and Stanley E.R. Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages. Mol Cell Biol 21 (2001) 1795-1809
15. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
16. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 (1996) C1424-C1437
17. Dennis E.A., Ackermann E.J., Deems R.A., and Reynolds L.J. Multiple forms of phospholipase A2 in macrophages capable of arachidonic acid release for eicosanoids biosynthesis. Adv Prostaglandin Thromboxane Leukotriene Res 23 (1995) 75-80
18. Balboa M.A., and Balsinde J. Oxidative stress and arachidonic acid mobilization. Biochim Biophys Acta 1761 (2006) 385-391
19. Cabral G.A. Lipids as bioeffectors in the immune system. Life Sci 77 (2005) 1699-1710
20. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
21. Jones G.E. Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol 68 (2000) 593-602
22. Kapoun A.M., Liang F., O'Young G., Damm D.L., Quon D., White R.T., Munson K., Lam A., Schreiner G.F., and Protter A.A. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94 (2004) 453-461
23. Klinger J.R., Warburton R., Carino G.P., Murray J., Murphy C., Napier M., and Harrington E.O. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells. Exp Cell Res 312 (2006) 401-410
24. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., and Nathan C.F. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5 (1991) 98-103
25. Li Y., and Trush M.A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253 (1998) 295-299
26. Frein D., Schildknecht S., Bachschmid M., and Ullrich V. Redox regulation: a new challenge for pharmacology. Biochem Pharmacol 70 (2005) 811-823
27. Vinten-Johansen J., Jiang R., Reeves J.G., Mykytenko J., Deneve J., and Jobe L.J. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. Hematol Oncol Clin North Am 21 (2007) 123-145
28. Izzi V., Chiurchiù V., and Baldini P.M. Pharmacological and clinical applications of natriuretic peptides: accepted knowledge or changing views?. Curr Pharm Anal 3 (2007) 195-204
29. Strassmann G., Patil-Koota V., Finkelman F., Fong M., and Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 180 (1994) 2365-2370
30. Oh-ishi S., Utsunomiya I., Yamamoto T., Komuro Y., and Hara Y. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur J Pharmacol 300 (1996) 255-259
31. Harizi H., Juzan M., Pitard V., Moreau J.F., and Gualde N. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168 (2002) 2255-2263
32. Brandt I., Lambeir A.M., Ketelslegers J.M., Vanderheyden M., Scharpe S., and De Meester I. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52 (2006) 82-87
33. Lambeir A.M., Durinx C., Scharpe S., and De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40 (2003) 209-294
34. Mentlein R. Dipeptidyl-peptidase IV (CD26) - role in the activation of regulatory peptides. Regul Pept 85 (1999) 9-24
35. Boerrigter G., Costello-Boerrigter L.C., Harty G.J., Lapp H., and Burnett Jr. J.C. Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation. Am J Physiol, Regul Integr Comp Physiol 292 (2007) R897-R901